Long-term efficacy of occlusive therapy with topical pimecrolimus in severe dyshidrosiform hand and foot eczema.
Schurmeyer-Horst
Funda
F
Luger
Thomas A
TA
Bohm
Markus
M
D000287:Administration, Topical; D000368:Aged; D001706:Biopsy; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D011146:Eczema, Dyshidrotic / Q000188:drug therapy* / Q000473:pathology; D005500:Follow-Up Studies; D005528:Foot; D006225:Hand; D006801:Humans; D008297:Male; D009779:Occlusive Dressings; D019696:Peptidylprolyl Isomerase / Q000037:antagonists & inhibitors; D012720:Severity of Illness Index; D016559:Tacrolimus / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors
D003879:Dermatologic Agents; C117268:pimecrolimus; D019696:Peptidylprolyl Isomerase; D016559:Tacrolimus